The 30-month stay gives branded drugmakers a prescribed amount of time to assert and resolve patent rights in court before FDA may approve a generic …
The 30-month stay gives branded drugmakers a prescribed amount of time to assert and resolve patent rights in court before FDA may approve a generic …